Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| MMAD | Monomethyl auristatin D (MMAD), a potent tubulin inhibitor, is a toxin payload and antibody drug conjugate. Uses: Adcs cytotoxin. Group: Pharmaceutical. CAS No. 203849-91-6. Pack Sizes: 10 mg. Product ID: BADC-00309. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Mono-Hydroxy Sugammadex | Mono-Hydroxy Sugammadex is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. CAS No. 2376607-99-5. Pack Sizes: 2.5 mg. Product ID: B2694-370196. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-1 | Sugammadex-1 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292567. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex Impurities | Sugammadex Impurities, integral to the biomedical realm, serve as reference benchmarks in the meticulous quality control of Sugammadex. This drug, pivotal in reversing neuromuscular blockade amid anesthesia, demands precise impurity identification and quantification to uphold medicinal safety and efficacy during surgical interventions, thereby enhancing procedural outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-R12 | Sugammadex-R12 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292569. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-R18 | Sugammadex-R18 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292570. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-R4 | Sugammadex-R4 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292571. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-R5 | Sugammadex-R5 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292572. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-R6 | Sugammadex-R6 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292573. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-R7 | Sugammadex-R7 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292574. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex sodium | Sugammadex, a modified γ-cyclodextrin, with a lipophilic core and a hydrophilic periphery, is an agent for reversal of neuromuscular blockade by the agent rocuronium in general anaesthesia. Group: Pharmaceutical. CAS No. 343306-79-6. Pack Sizes: 100 mg. Product ID: B0046-475662. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vat-Cit-PAB-MMAD | Vat-Cit-PAB-MMAD is a protective group conjugated MMAD, MMAD is a toxin payload in antibody drug conjugate. Group: Pharmaceutical. CAS No. 1415329-13-3. Pack Sizes: 5 mg. Product ID: BADC-00016. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| γ-Cyclodextrin | γ-Cyclodextrin is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. CAS No. 17465-86-0. Pack Sizes: 100 g. Product ID: B1999-003038. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
